Posttraumatic stress disorder: psychopathology, medical management, and dental implications (Q35625791)

9 August 2017

1 reference

title

Posttraumatic stress disorder: psychopathology, medical management, and dental implications (English)

1 reference

post-traumatic stress disorder

9 August 2017

main subject

1 reference

Arthur H Friedlander

1

1 reference

9 August 2017

Ida K Friedlander

series ordinal

2

1 reference

9 August 2017

Stephen R Marder

series ordinal

3

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

9 August 2017

published in

1 reference

9 August 2017

volume

97

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

5-11

1 reference

Post-traumatic stress disorder

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Psychophysiology of post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Harmful drinking in military veterans with post-traumatic stress disorder: association with the D2 dopamine receptor A1 allele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Substance use disorders in patients with posttraumatic stress disorder: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Posttraumatic stress disorder and drug disorders: testing causal pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Health impact of interpersonal violence. 2: Medical and mental health outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Violent assault, posttraumatic stress disorder, and depression. Risk factors for cigarette use among adult women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Relationship of physical symptoms to posttraumatic stress disorder among veterans seeking care for gulf war-related health concerns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Medical service utilization by veterans seeking help for posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

An investigation of the impact of posttraumatic stress disorder on physical health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Posttraumatic stress disorder in the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Guidelines for treatment of PTSD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Vulnerability to assaultive violence: further specification of the sex difference in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Psychiatric disorders among survivors of the Oklahoma City bombing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

A National Survey of Stress Reactions after the September 11, 2001, Terrorist Attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Biological markers and diagnostic accuracy in the genetics of posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Hippocampal volume in women victimized by childhood sexual abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Future pharmacotherapy for post-traumatic stress disorder: prevention and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Neuropsychological processes in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Neuroimaging studies in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Biologic models of traumatic memories and post-traumatic stress disorder. The role of neural networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Implications of biological findings for psychological treatments of post-traumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

A meta-analytic examination of basal cardiovascular activity in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Psychosocial treatments for posttraumatic stress disorder: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Treatment of Posttraumatic Stress Disorder by Exposure and/or Cognitive Restructuring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Cognitive therapy or imaginal exposure in the treatment of post-traumatic stress disorder. Twelve-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Maximizing treatment outcome in post-traumatic stress disorder by combining psychotherapy with pharmacotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

The psychobiology and psychopharmacology of PTSD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Selective serotonin reuptake inhibitors in the treatment of post-traumatic stress disorder: a meta-analysis of randomized controlled trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Finding a home for post-traumatic stress disorder in biological psychiatry. Is it a disorder of anxiety, mood, stress, or memory?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Systematic review and guide to selection of selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Nefazodone treatment for chronic posttraumatic stress disorder: an open trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Divalproex in posttraumatic stress disorder: an open-label clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Antiepileptic drugs in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Dental management considerations for the patient with post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Prevalence of post-traumatic stress disorder in patients with chronic idiopathic facial pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Etiologic models for incident periodontal attachment loss in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Psychosocial factors and adult onset rapidly progressive periodontitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Psychosocial factors in inflammatory periodontal diseases. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Psychological mood of regular dental attenders in relation to oral hygiene behaviour and gingival health.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Exploratory case-control analysis of psychosocial factors and adult periodontitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Immunity in young adults with major depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Reported bruxism and stress experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Factors associated with the temporomandibular disorder, pain dysfunction syndrome (PDS): Manchester case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Risk factors for sleep bruxism in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Selective serotonin-reuptake inhibitor-induced movement disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Antidepressant-induced bruxism successfully treated with gabapentin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Study shows link between antidepressants, bruxism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Taste and smell perception in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Depressive symptoms favor abundant growth of salivary lactobacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Comparison of nutrient intake among depressed and nondepressed individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Comorbidity of depression with chronic facial pain and temporomandibular disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Major psychological disorders in acute and chronic TMD: an initial examination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Medically unexplained chronic orofacial pain. Temporomandibular pain and dysfunction syndrome, orofacial phantom pain, burning mouth syndrome, and trigeminal neuralgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Burning mouth syndrome: prevalence and associated factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Clinical assessment and outcome in 70 patients with complaints of burning or sore mouth symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Alcoholic parotid sialadenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Idiopathic epistaxis, haemostasis and alcohol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Alcohol and platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Evaluating the clinical significance of drug interactions: a systematic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Mechanisms of ethanol-drug-nutrition interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Dosing issues in the pharmacotherapy of alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Nefazodone in post-traumatic stress disorder: results from six open-label trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

Is major depression comorbid with temporomandibular pain and dysfunction syndrome? A pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRIPLEO.2003.09.004

1 reference

9 August 2017

1 reference